XJPX
2150
Market cap297mUSD
Dec 22, Last price
11,239,999,488.00JPY
Name
CareNet Inc
Chart & Performance
P/E
409,072,583.26
P/S
41,695,529.64
EPS
27.48
Div Yield, %
0.00%
Shrs. gr., 5y
0.86%
Rev. gr., 5y
27.89%
Revenues
11.18b
+9.25%
Net income
1.14b
-24.54%
CFO
1.82b
+5.88%
Dividend
Dec 27, 202412 JPY/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Established in 1996 and headquartered in Tokyo, Japan, CareNet, Inc. primarily offers pharmaceutical sales assistance to drug manufacturers throughout the country. The company also provides essential medical content services tailored for physicians and other healthcare practitioners. Its comprehensive digital portfolio encompasses: CareNet.com: A membership-based online platform delivering vital medical and clinical information for daily professional use. PubMedCLOUD: A specialized tool for searching and organizing PubMed articles, localized for Japanese users. Doctors'Picks: An online community where medical experts curate and recommend specialized news to their peers. CareNeTV: A dedicated channel focused on clinical medicine. CareNet DVD: Educational materials providing clinical medical instruction via DVD. CareNet Career: A service designed to guide CareNet members, particularly doctors, through job changes and employment searches. Additionally, CareNet, Inc. facilitates the distribution of medical information from pharmaceutical companies directly to its doctor members via MR Plus, an internet-based service, and offers live-streamed educational presentations through its Web Lecture platform.
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||